Tinavi (天智航, 688277.SH), one of the largest domestic surgical robot manufacturers, announced on October 15 that its innovative surgical system had been certified by China’s medical equipment regulator, becoming what it says is the first company worldwide to produce a three-in-one surgical robot.
In an exchange filing, the Beijing-based surgical robot pioneer said it had recently received the official greenlight for changes to the application scope of its third-generation orthopedic surgical navigation platform.
This official stamp of approval established Tinavi as a supplier of surgical robots that are not just able to perform procedures on spinal cord or conduct open percutaneous surgeries, but also replace keen joints.
Following this regulatory change, Tinavi is officially able to extend its reach across three major business categories, covering spinal cord disorder, joint replacement and open wound treatment — all with one piece of surgical equipment.
All it needs is to change the accessories and software.
This development has been hailed as a significant achievement by a Chinese surgical robot company. It represents the transition of the industry from a laggard trying to catch up with market incumbents to a world-class player with a knack for its own disruptive innovations.
